Vasculitis related to hepatitis B vaccine.

can Isolated hepatitis B core antibody in HIV-infected patients response to hepatitis B vaccine help to elucidate the cause?

Surface protein mutations in chronic hepatitis B patients who received hepatitis B vaccine therapy

Objective (s):The aim of this study was to determine the correlation between vaccine therapy and appearance of mutations in hepatitis B surface antigen (HBsAg)-positive chronic hepatitis B virus (HBV) patients. Materials and Methods: 16 patients received the HBV vaccine and another 16 individuals from the control group did not. The surface gene was amplified and directly sequenced from samples...

Hepatitis B vaccine.

Many Vaccine Information Statements are available in Spanish and other languages. See www.immunize.org/vis. 1 What is hepatitis B? Hepatitis B is a serious disease that affects the liver. It is caused by the hepatitis B virus (HBV). HBV can cause: Acute (short-term) illness. This can lead to: • loss of appetite • diarrhea and vomiting • tiredness • jaundice (yellow skin or eyes) • pain in muscl...

Immune responses to hepatitis B vaccine.

chronic carriers worldwide.1 The highest carrier rate is in Asia and Africa. 2 Chronic infection develops among 90% of newborns, 29-40% of children and 5-10% of adults.3 Patients with long-standing active liver disease are at high risk of developing liver cirrhosis and hepatocellular carcinoma.4 Hepatitis B virus is responsible for 80% of liver cancer cases in the world.5 Therefore, prevention ...

Distribution of Circulating Immune Cells in Responder and Non-Responder Individuals to Hepatitis B Vaccine

Unresponsiveness to hepatitis B surface antigen (HBsAg) has been shown to be associated with dysfunction of the presenting cells (APC) and defect in the specific B-lymphocyte and/or T-lymphocyte repertoires.   Direct determination of the frequency of specific T-lymphocytes together with complementary analysis of the naive circulating immune cells could provide valuable information about the cel...